We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
-0.36%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$3.53B
AUM Growth
+$77.1M
Cap. Flow
+$137M
Cap. Flow %
3.88%
Top 10 Hldgs %
30.93%
Holding
290
New
27
Increased
78
Reduced
89
Closed
20

Top Buys

1
WHR icon
Whirlpool
WHR
+$83.4M
2
ADI icon
Analog Devices
ADI
+$72.5M
3
CELG
Celgene Corp
CELG
+$62.7M
4
EQT icon
EQT Corp
EQT
+$56.9M
5
GS icon
Goldman Sachs
GS
+$56.3M

Top Sells

1
MU icon
Micron Technology
MU
+$76.6M
2
GILD icon
Gilead Sciences
GILD
+$67.5M
3
PXD
Pioneer Natural Resource Co.
PXD
+$65M
4
AL
Air Lease Corp
AL
+$32.4M
5
IRM icon
Iron Mountain
IRM
+$30.6M

Sector Composition

1 Healthcare 22.12%
2 Industrials 21.48%
3 Technology 11.2%
4 Energy 10.54%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVEO
251
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$222K 0.01%
12,750
+980
+8% +$17.6K
GDXJ icon
252
VanEck Junior Gold Miners ETF
GDXJ
$6.68B
$220K 0.01%
+9,125
New +$230K
AXP icon
253
American Express
AXP
$243B
$210K 0.01%
+2,700
New +$214K
MPC icon
254
Marathon Petroleum
MPC
$89.8B
$209K 0.01%
4,000
– –
MMP
255
DELISTED
Magellan Midstream Partners, L.P.
MMP
$205K 0.01%
2,800
– –
CMO
256
DELISTED
Capstead Mortgage Corp.
CMO
$203K 0.01%
+18,300
New +$216K
LPSN icon
257
LivePerson
LPSN
$20.8M
$196K 0.01%
+1,333
New +$194K
MCS icon
258
Marcus Corp
MCS
$699M
$194K 0.01%
10,100
– –
IRWD icon
259
Ironwood Pharmaceuticals
IRWD
$645M
$190K 0.01%
18,770
-1,194
-6% -$13.9K
ROKA
260
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$190K 0.01%
7,320
+5,000
+216% +$147K
OB
261
DELISTED
Onebeacon Insurance Group Ltd
OB
$145K ﹤0.01%
10,000
– –
RIBT
262
DELISTED
RiceBran Technologies
RIBT
$144K ﹤0.01%
+4,241
New +$153K
IMBI
263
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$135K ﹤0.01%
+5,000
New +$238K
GNMK
264
DELISTED
GenMark Diagnostics, Inc
GNMK
$91K ﹤0.01%
+10,000
New +$101K
BNBX
265
DELISTED
BNB PLUS CORP
BNBX
– –
0
– –
PVCT
266
DELISTED
PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT
$49K ﹤0.01%
+90,000
New +$73.4K
KOPN icon
267
Kopin
KOPN
$719M
$38K ﹤0.01%
+11,000
New +$39.3K
ONCT
268
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$29K ﹤0.01%
+14
New +$19.9K
TLOG
269
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$27K ﹤0.01%
+11,713
New +$36.1K
MHR
270
DELISTED
MAGNUM HUNTER RESOURCES CORP (DEL)
MHR
$22K ﹤0.01%
12,000
– –
AR icon
271
Antero Resources
AR
$10.3B
– –
-846,115
Closed -$29.9M
BEN icon
272
Franklin Resources
BEN
$17B
– –
-6,000
Closed -$308K
F icon
273
Ford
F
$57.4B
– –
-1,804,940
Closed -$29.1M
GEN icon
274
Gen Digital
GEN
$16.2B
– –
-528,940
Closed -$12.4M
IRM icon
275
Iron Mountain
IRM
$36.8B
– –
-837,590
Closed -$30.6M
8 9 10
11
12

Similar funds

GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return
PMEF
Point72 Middle East FZE Dubai, United Arab Emirates $3.38B AUM 14.09% 1-Year Est. Return
SS
Simplicity Solutions Minneapolis, Minnesota $3.66B AUM 23.51% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
WP
WealthSource Partners San Luis Obispo, California $1.54B AUM 16.68% 1-Year Est. Return
BWM
Baystate Wealth Management Boston, Massachusetts $1.36B AUM 15.87% 1-Year Est. Return
DI
DFPG Investments Sandy, Utah $1.28B AUM 27.55% 1-Year Est. Return

Cannell & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Cannell & Co held 290 positions worth $3.53B, up 2.2% from $3.45B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Cannell & Co deployed $137M of net new capital in Q2 2015, opening 27 new positions and adding to 78 existing holdings. Its largest new stake was Golar LNG: 1,035,540 shares worth $48.5M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Gilead Sciences, an estimated $67.5M trimmed.

  • Cannell & Co's largest Q2 2015 buy was Golar LNG: 1,035,540 shares worth $48.5M.
  • Cannell & Co added most to Whirlpool in Q2 2015, an estimated $83.4M increase.
  • Cannell & Co's biggest Q2 2015 reduction was Gilead Sciences, cutting an estimated $67.5M.
  • Cannell & Co fully exited Micron Technology in Q2 2015, selling an estimated $76.6M.
  • Cannell & Co's ten largest holdings make up 31% of its $3.53B portfolio in Q2 2015.
  • Cannell & Co opened 27 new positions and closed 20 in Q2 2015.
  • Cannell & Co's portfolio value rose 2.2% quarter-over-quarter to $3.53B.

Based on Cannell & Co's 13F filing for Q2 2015, filed 13 Aug 2015.